The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer

NCT00440128 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Nausea and Vomiting, Chemotherapy-Induced

Interventions

DRUG: Docetaxel
DRUG: Casopitant/Docetaxel

Sponsor

GlaxoSmithKline